BPMC
Price
$90.14
Change
+$1.21 (+1.36%)
Updated
Dec 20 closing price
53 days until earnings call
ORMP
Price
$2.38
Change
-$0.11 (-4.42%)
Updated
Dec 20, 04:59 PM (EDT)
66 days until earnings call
Ad is loading...

BPMC vs ORMP

Header iconBPMC vs ORMP Comparison
Open Charts BPMC vs ORMPBanner chart's image
Blueprint Medicines
Price$90.14
Change+$1.21 (+1.36%)
Volume$1.27M
CapitalizationN/A
Oramed Pharmaceuticals
Price$2.38
Change-$0.11 (-4.42%)
Volume$2.34K
CapitalizationN/A
BPMC vs ORMP Comparison Chart
Loading...
BPMC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BPMC vs. ORMP commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BPMC is a Hold and ORMP is a Hold.

COMPARISON
Comparison
Dec 23, 2024
Stock price -- (BPMC: $90.14 vs. ORMP: $2.37)
Brand notoriety: BPMC and ORMP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BPMC: 183% vs. ORMP: 66%
Market capitalization -- BPMC: $5.73B vs. ORMP: $95.94M
BPMC [@Biotechnology] is valued at $5.73B. ORMP’s [@Biotechnology] market capitalization is $95.94M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BPMC’s FA Score shows that 0 FA rating(s) are green whileORMP’s FA Score has 0 green FA rating(s).

  • BPMC’s FA Score: 0 green, 5 red.
  • ORMP’s FA Score: 0 green, 5 red.
According to our system of comparison, ORMP is a better buy in the long-term than BPMC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BPMC’s TA Score shows that 3 TA indicator(s) are bullish while ORMP’s TA Score has 3 bullish TA indicator(s).

  • BPMC’s TA Score: 3 bullish, 4 bearish.
  • ORMP’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, BPMC is a better buy in the short-term than ORMP.

Price Growth

BPMC (@Biotechnology) experienced а -3.27% price change this week, while ORMP (@Biotechnology) price change was -4.05% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.20%. For the same industry, the average monthly price growth was -1.27%, and the average quarterly price growth was +2.17%.

Reported Earning Dates

BPMC is expected to report earnings on Feb 13, 2025.

ORMP is expected to report earnings on Feb 26, 2025.

Industries' Descriptions

@Biotechnology (-2.20% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BPMC($5.73B) has a higher market cap than ORMP($95.9M). ORMP YTD gains are higher at: 2.597 vs. BPMC (-2.277). ORMP has higher annual earnings (EBITDA): 9.44M vs. BPMC (-75.58M). BPMC has more cash in the bank: 734M vs. ORMP (142M). ORMP has less debt than BPMC: ORMP (429K) vs BPMC (471M). BPMC has higher revenues than ORMP: BPMC (434M) vs ORMP (0).
BPMCORMPBPMC / ORMP
Capitalization5.73B95.9M5,974%
EBITDA-75.58M9.44M-801%
Gain YTD-2.2772.597-88%
P/E RatioN/A21.64-
Revenue434M0-
Total Cash734M142M517%
Total Debt471M429K109,790%
FUNDAMENTALS RATINGS
BPMC vs ORMP: Fundamental Ratings
BPMC
ORMP
OUTLOOK RATING
1..100
7172
VALUATION
overvalued / fair valued / undervalued
1..100
80
Overvalued
67
Overvalued
PROFIT vs RISK RATING
1..100
80100
SMR RATING
1..100
9784
PRICE GROWTH RATING
1..100
5949
P/E GROWTH RATING
1..100
6748
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ORMP's Valuation (67) in the Pharmaceuticals Other industry is in the same range as BPMC (80) in the Biotechnology industry. This means that ORMP’s stock grew similarly to BPMC’s over the last 12 months.

BPMC's Profit vs Risk Rating (80) in the Biotechnology industry is in the same range as ORMP (100) in the Pharmaceuticals Other industry. This means that BPMC’s stock grew similarly to ORMP’s over the last 12 months.

ORMP's SMR Rating (84) in the Pharmaceuticals Other industry is in the same range as BPMC (97) in the Biotechnology industry. This means that ORMP’s stock grew similarly to BPMC’s over the last 12 months.

ORMP's Price Growth Rating (49) in the Pharmaceuticals Other industry is in the same range as BPMC (59) in the Biotechnology industry. This means that ORMP’s stock grew similarly to BPMC’s over the last 12 months.

ORMP's P/E Growth Rating (48) in the Pharmaceuticals Other industry is in the same range as BPMC (67) in the Biotechnology industry. This means that ORMP’s stock grew similarly to BPMC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BPMCORMP
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 3 days ago
73%
Momentum
ODDS (%)
Bearish Trend 3 days ago
74%
Bearish Trend 3 days ago
79%
MACD
ODDS (%)
Bearish Trend 3 days ago
68%
Bearish Trend 3 days ago
81%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
74%
Bearish Trend 3 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
75%
Bullish Trend 3 days ago
85%
Advances
ODDS (%)
Bullish Trend 6 days ago
73%
Bullish Trend 4 days ago
82%
Declines
ODDS (%)
Bearish Trend 4 days ago
73%
Bearish Trend 6 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
83%
Bearish Trend 3 days ago
83%
Aroon
ODDS (%)
N/A
Bearish Trend 3 days ago
84%
View a ticker or compare two or three
Ad is loading...
BPMC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
FMAT48.660.51
+1.05%
Fidelity MSCI Materials ETF
GCAD34.340.27
+0.80%
Gabelli Commercial Aerospace & Dfns ETF
HYLB36.260.21
+0.58%
Xtrackers USD High Yield Corp Bd ETF
XTWY39.190.07
+0.17%
BondBloxx Bloomberg TwentyYrTrgDuUSTrETF
PCGG11.950.01
+0.12%
Polen Capital Global Growth ETF

ORMP and

Correlation & Price change

A.I.dvisor indicates that over the last year, ORMP has been loosely correlated with BPMC. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if ORMP jumps, then BPMC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORMP
1D Price
Change %
ORMP100%
-4.82%
BPMC - ORMP
44%
Loosely correlated
+1.36%
BTAI - ORMP
44%
Loosely correlated
+8.12%
INO - ORMP
44%
Loosely correlated
-0.27%
MBIO - ORMP
44%
Loosely correlated
+1.64%
VERV - ORMP
44%
Loosely correlated
+11.24%
More